PRMT1 and Parkinson disease: Although further research is needed, it could be, therefore, speculated that PRMT6 and PRMT1 can activate and deactivate FOXO3, respectively, thereby affecting several key mechanisms in PD, such as apoptosis, neuroinflammation, autophagy dysregulation, oxidative damage, and α-synuclein aggregation.